Blue Horseshoe Stocks: FL Recap & More

Footlocker, Inc. FL – Recap

On Friday, we cited a big profit and sales beat on Foot Locker’s Q1 earnings report, noting that we have had good luck with the company’s earning chain in the past. Our designated targets were the FL 06/15 $52.50-55 Calls. Lightning struck for us once again as FL surged and our ideas took off.

The $52.50 Calls ran hard from a low of 1.30 and subsequently hit a high of 4.50. That works out to a daily rip of 246% Meanwhile, the $55 Calls went on a slightly more intense ride, trading in a range from .65-2.54 for total possible intraday gains of 291%


ArQule, Inc. ARQL
It was just this past Wednesday morning that we were mentioning our late April call on ARQL which allowed us to catch the stock when it was trading as low as 2.40. ARQL had, at the time of last week’s mention, breached into the four-dollar range, but after a fruitful finish to the week, we have to circle back to comment on its impressive new highs.

In its fifth consecutive trading day of posting higher lows and higher highs, the stock reached a new high of 5.29, pushing our one month observed increase on the stock to 120%



Tintri, Inc. TNTR

We also want to place TNTR on bottom watch as we kick off the short trading week, after noticing that the stock has been absolutely crushed in the past week. It had already been on a steady downward trajectory, but as you can see below, the selloff really kicked into high gear just last week.

We’ve also noticed a rapid rise in the short volume, accounting for more than 1.2M of the stocks total volume on Friday. With the stock already having been egregiously oversold, this type of scenario can often lead to a short squeeze, and we will want to be ready to ride TNTR on the way back up, if that occurs.


Extended Watchlist:
ABIO, SBOT, MYSZ, CVPR, LPL, KTOV, OLED, VPLM(News)

Blue Horseshoe Stocks: ABIO Recap & More

ARCA BioPharma, Inc. ABIO

Our top performer from yesterday’s report was most assuredly ABIO. We tagged this play after noticing that it had announced being granted orphan drug status by the FDA for “rNAPc2″ as a potential treatment of viral hemorrhagic fever post-exposure to the Ebola virus.

Fresh FDA-related plays can often provide a healthy move to take advantage of, and that’s just what we got from ABIO, The stock traded in a range from .82-1.03, an intraday increase of 25% on nearly ten times the 3-month average volume.

Our long-time readers might recall our coverage of this stock last year in December, which sort of got lost in the shuffle that was the hysteria created by the “Green Rush”. We tracked the stock from the low 1.40′s to over 2.20 over a period of a few weeks, so it will be interesting to see if history continues to repeat itself with ABIO, especially with the stock coming off of it 52-week low on Tuesday.


CYREN Ltd. CYRN

We also wanted to acknowledge the early morning move made by another of the stocks we mentioned in yesterday’s newsletter, CYRN. It bolted out of the gate, quickly running from 2.22 to 2.67, a 20% spike within the first 15 minutes of the session.

The stock got hammered into the close quite a bit, so we’ll be open to the possibility of seeing some bounce action, provided it can hold support at or above the 50DMA of 1.75.


Office Depot, Inc. ODP

ODP is in the midst of making a big move on the heels of large activist investor Starboard Value taking up a position which equates to 6% of ODP’s total shares. It also upped its stake in Staples to 10% fueling speculation that it could create pressure for the two office supply giants to merge. It will definitely be a story that we’ll be interested to follow moving forward.


Extended Watchlist:
GPT, RGDX, CYTX, DRD

Blue Horseshoe Stocks: LXRP News Update & FDA-Related Plays

Lexaria Corp. LXRP

Following our initial report on LXRP yesterday, the stock had a productive session as it traded in a range from .095 to a high of .108, an intraday gain of 14% on roughly 2.5X the monthly average volume. It closed at .102 holding more than half of the day’s gains, which is generally a good sign.

We promised to relay any further updates regarding the current status of LXRP, and sure enough the company published a fresh PR this morning containing another major development. It relates to the sale of Lexaria’s domestic oil assets, which we mentioned in yesterday’s report, becoming final with all funds received. It provides LXRP with a cash infusion of $1.4M which will facilitate a clearing of all debt currently on the books, as well as advance the company’s plans to release a CBD-infused tea (infusion method is patent pending) via a new online sales portal. With the rate at which LXRP has been executing its strategies, we expect to hear about the opening of that website any day now.

KELOWNA, BC / ACCESSWIRE / December 10, 2014 / Lexaria Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”) is pleased to announce the sale of all its Belmont Lake oil assets for $1.4 million in cash has closed and all money received. Lexaria congratulates the new owners for having purchased a fine asset. >> FULL PR


FDA-Related News

We caught a couple of FDA news plays on this morning’s scan that we’ll want to keep an eye on:

ARCA BioPharma, Inc. ABIO has reported that the FDA “has granted orphan drug designation to rNAPc2 as a potential treatment of viral hemorrhagic fever post-exposure to Ebola virus.” >> VIEW PR

Cytori Therapeutics, Inc. CYTX announced that the FDA granted approval “for a pivotal clinical trial, named the ‘STAR’ trial, to evaluate Cytori Cell Therapy™ as a potential treatment for impaired hand function in scleroderma, a rare autoimmune disease affecting approximately 50,000 patients in the United States.” >> VIEW PR


Extended Watchlist:
 CYRN, SYMX, SNSS

Blue Horseshoe: Pot Stocks Still Soaring, VRS, PLUG & More

Pot Stocks Still Soaring
-
Why have we been pounding the table so hard on marijuana stocks lately? The simple answer is that they have stolen the show thus far in 2014, piling on monstrous gains left, right , and center. It is literally the hottest OTC sector right now, so if you’re sick of us talking about it day in and day out, we’re not sure why! A person would have to hate making money to not be interested in the magic we’ve been witnessing in stocks that have even the slightest connection to cannabis. So many of these gems have been on the move, that it’s impossible to mention them all, but here are a few of the more substantial gainers from yesterday’s session. Some of them rose so much it borders on the surreal!
-
GreenGrow Technologies, Inc. GRNH

We were lauding GRNH yesterday morning for the wonderful 311% gain it had afforded us from our alert low of .045 to .185. However, that was only a taste of what was in store for us. GRNH morphed into a hulking beast as it pushed the envelope all day long, rocketing to a high of .55! From yesterday’s daily low (for all those who have been sleeping under a rock for the past week) gains of 162% were possible on the day; but from our recent low of .045, the gains are far more impressive, to the tune of 1122% in only FOUR trading sessions! It’s kind of hard not to pat ourselves heartily on the back for that one. It’s not too often we see a ten-bagger, and we were all over this one like white on rice!

Creative Edge Nutrition, Inc. FITX

The more we think about it, the more we’re realizing that yesterday’s report read less like a newsletter, and more like a who’s-who of winning picks. From our recently observed low of .0054 (Monday), FITX absolutely tore its way to a high of .0189, representing a two-day move of 250%  Even those showing up late to the party, only catching yesterday’s report, could have ended up with single-session gains of up to 170%

Tranzbyte Corp. ERBB

ERBB also put forth a performance worthy of celebration yesterday. Our morning mention included congratulating our readers on a 35% possible gain from the day prior, as we had witnessed a low of .0026. Yesterday, the stock followed up a good performance with a great one, trading in a range from .0038-.0086 (+126%). From our alert low on ERBB at .0026, yesterday’s high marks a 231% increase, practically overnight.

In addition to those monstrous gainers, there were those that put up more modest, yet still significant increases:

Terra Tech Corp. TRTC

Daily Range: .193-.2545  Max Gain: 32%

Cannabis Science, Inc. CBIS

Daily Range: .07-.09    Max Gain: 29%

Hemp, Inc. HEMP

Daily Range: .03-.041  Max Gain: 37%

Added Note: We also have a couple of new marijuana stocks to add to our huge tracking list: CANN, AVTC

***UPDATE 10:30am*** Easton Pharmaceuticals, Inc. EAPH – We are adding another company that has aspirations of entering the cannabis industry. Per an October PR, EAPH has announced its desire to become one of Canada’s largest medical marijuana distributors, importing from countries like Uruguay and Holland. We are placing this stock on watch as it is in the process of breaking out today, and will continue to monitor its progress.


Verso Paper Corp. VRS

Switching gears from our cannabis plays, we have another winner in VRS which came off of yesterday’s extended watchlist to have a bang-up session. The stock saw a low of 3.50 before surging to 5.55, good for an intraday gain of 59%


Plug Power, Inc. PLUG

PLUG has been a source of solid gains for us in the recent past as well, and the stock piled on yet another nice performance Tuesday following a tag in our extended watchlist. From a low of 3.05, PLUG pushed as high as 4.14, giving traders the chance at daily gains of up to 36%


Neurocrine Biosciences, Inc. NBIX

NBIX rounds off our huge group of Tuesday’s winners; after placing it on yesterday’s extended watchlist the stock made a nice run from a low of 15.20, on up to 18.62. That was good for an intraday move of 23%


As you can plainly see, we have been almost unable to find a losing pick so far in 2014! If you aren’t reading this report in your inbox, why not get over to our SIGNUP FORM and get subscribed to our daily pre-market alerts, which more often than not contain winners just like these. Each year, we promise greater success than the year before, and we seldom fail to deliver. 2014 has been no different, it has been a veritable trader’s paradise, so stay tuned into our reports and good luck out there! 


Extended Watchlist:
PATH, CPRX, RNN, ABIO, CYTR

TSLA, PLUG, ETRM, OMED & Extended Watchlist

Tesla Motors, Inc. TSLA – Options
-
Back on November 29th, we were noticing that conditions on the TSLA chart had been exhibiting signs of a coming uptrend, and as a result, we presented a few options trading ideas that we felt had a reasonable chance of success. In particular, the 12/21 $120 Calls, and the 12/27 $130 Calls. We were rewarded for our interest, as the stock did indeed find its legs and begin to run following that report.

Since then we’ve seen some major moves out of those contracts, as the $120 Calls ended up trading from a low of 8.40, all the way up to yesterday’s closing price of 25.46, a monstrous 203% gain. The $130 Calls saw their low at 5.03, and ended up closing at 17.07. That was good for an even larger 239% rip.

Chartwise, it appears as if resistance is sitting at $145.65, $151, and the 50DMA of $159.45, and there is a gap on the chart to fill from $160-176, so a push past those key resistance points could lead to more pronounced increases. We would continue to take advantage of the added gains on these contracts, and in the event of a sustained uptrend, would have to consider rolling our strike price up to higher level that we believe would still be pushed into the money.


Plug Power, Inc. PLUG

PLUG has been an old favorite of ours from last March when we caught it on our scanners coming off its 52-wk lows (.1155) and we’ve mentioned it on multiple occasions since that time. We’ve followed this play all the way up to current levels, which as a result of recent favorable reports on the company’s finances, have reached all the way up to this morning’s pre-market high of 1.41. That represents an increase of 1121% off of lows following our initial alert.

We’ll be continuing to monitor PLUG closely, and will certainly want to take part in today’s conference call/webcast in which the CEO will address the reasoning behind his statement that the company is on pace for a “blowout quarter.”, as well as other issues.

LATHAM, N.Y., Dec 04, 2013 (GLOBE NEWSWIRE via COMTEX) — Plug Power Inc. (Nasdaq:PLUG), a leader in providing clean, reliable energy solutions, will today host a conference call and webcast during which CEO Andy Marsh will provide a business update for Plug Power and the Company’s expectations for the remainder of 2013 and for 2014.Since the October 8 business update call, the Company has seen an additional 17.8M USD in bookings. Plug Power is currently in negotiations with several large customers on sales agreements to deploy turn-key GenDrive solutions at multiple distribution centers. The Company believes this will significantly impact the fourth quarter bookings, as well as provide a recurring revenue stream from product, service and hydrogen contracts. Plug Power expects orders to range between 30M and 40M USD for the fourth quarter of 2013.

Plug Power has scheduled its conference call and webcast today at 10:30 am ET to review the Company’s business updates. Participants are encouraged to join the webcast to access the accompanying slide show presentation. The webcast can be accessed by going directly to the Plug Power Web site (www.plugpower.com) and selecting the webcast link on the home page. You can also call-in by dialing 877.407.8291. Andy Marsh will be joined by COO, Keith Schmid, and Vice President of Sales, Erik Hansen, to answer questions.


EnteroMedics, Inc. ETRM

ETRM was part of yesterday’s Extended Watchlist, and the stock went on to put up quite a performance. After touching a low of 1.48 shortly before 10:30am, ETRM would spend the rest of the day pressing upward to its high of day and closing price at 2.24. This marks an impressive intraday run of 51% on nearly 20x its 3mo. average volume.

We’ll certainly want to keep an eye on a stock with current momentum of this magnitude.


OncoMed Pharmaceuticals, Inc. OMED

Another winner from yesterday’s Extended Watchlist, OMED traded in a range from 22.10-31.99, which marks an intraday move of 45% Quite an impressive feat for a big-board stock in this price range.

Congrats to anyone who caught this, or any of the opportunities for significant profits afforded by the excellent calls in yesterday’s report.


Extended Watchlist:
IACH, BLDP, FCEL, CCXI, ABIO, IMMU, CPST, RAD, ICLD, CYTR,
HEM (Recently coming off 52week lows),
OCLS (FDA Approval news out this am)